Bicycle Therapeutics PLC Announces Inducement Awards for New Employees
BCYC Stock | USD 13.34 0.25 1.84% |
About 62% of Bicycle Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Bicycle Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Bicycle Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Bicycle Therapeutics stock news signals to limit their universe of possible portfolio assets.
Bicycle |
Summary Bicycle Therapeutics PLC , a clinical-stage pharmaceutical company, announced on January 2, 2025, that its Compensation Committee has granted indu
Read at gurufocus.com
Bicycle Therapeutics Fundamental Analysis
We analyze Bicycle Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bicycle Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bicycle Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Bicycle Therapeutics is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Bicycle Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bicycle Therapeutics stock to make a market-neutral strategy. Peer analysis of Bicycle Therapeutics could also be used in its relative valuation, which is a method of valuing Bicycle Therapeutics by comparing valuation metrics with similar companies.
Peers
Bicycle Therapeutics Related Equities
MGTX | MeiraGTx Holdings | 5.56 | ||||
ANAB | AnaptysBio | 5.46 | ||||
ACRV | Acrivon Therapeutics, | 4.14 | ||||
KROS | Keros Therapeutics | 3.23 | ||||
CCCC | C4 Therapeutics | 2.07 | ||||
CGEM | Cullinan Oncology | 1.18 | ||||
TNYA | Tenaya Therapeutics | 0.72 | ||||
INBX | Inhibrx | 0.37 | ||||
MRUS | Merus BV | 0.50 | ||||
ADAG | Adagene | 0.54 | ||||
SEER | Seer | 0.87 | ||||
STOK | Stoke Therapeutics | 1.06 | ||||
GLUE | Monte Rosa | 1.74 | ||||
ANEB | Anebulo Pharmaceuticals | 1.85 | ||||
IDYA | Ideaya Biosciences | 2.38 | ||||
MLYS | Mineralys Therapeutics, | 2.74 | ||||
IGMS | IGM Biosciences | 3.28 | ||||
ORIC | Oric Pharmaceuticals | 4.58 |
Complementary Tools for Bicycle Stock analysis
When running Bicycle Therapeutics' price analysis, check to measure Bicycle Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicycle Therapeutics is operating at the current time. Most of Bicycle Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicycle Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicycle Therapeutics' price. Additionally, you may evaluate how the addition of Bicycle Therapeutics to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |